Vor Biopharma Inc.
VORUnited States
23 filed reports · 254 financial concepts · 0 earnings calls · 0 media appearances
Filed reports
23 reports · Mar 2021 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 17 | 2,002 | Mar 2021 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 5 | 1,634 | Dec 2021 to Dec 2025 |
| Quarterly · 10-Q/ASEC EDGAR | 1 | 1 | Mar 2024 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 11, 2026 | 282 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 13, 2026 | 154 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Mar 30, 2026 | 479 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 13, 2025 | 179 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 12, 2025 | 105 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 14, 2025 | 103 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Mar 20, 2025 | 300 | Open |
| FY2024 Q3 | 10-Q | Sep 30, 2024 | Nov 7, 2024 | 110 | Open |
| FY2024 Q2 | 10-Q | Jun 30, 2024 | Aug 8, 2024 | 99 | Open |
| FY2024 Q1 | 10-Q/A | Mar 31, 2024 | Aug 8, 2024 | 1 | Open |
| FY2024 Q1 | 10-Q | Mar 31, 2024 | May 9, 2024 | 102 | Open |
| FY2023 | 10-K | Dec 31, 2023 | Mar 20, 2024 | 299 | Open |
Financial data
254 concepts · 3,637 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial253 concepts · 3,629 facts · Dec 2019 to Jun 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value32 · Mar 2020 to Jun 2026
- Allocated share based compensation expense32 · Mar 2020 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents including disposal group and discontinued operations32 · Mar 2020 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect32 · Mar 2020 to Jun 2026
- Depreciation32 · Mar 2020 to Jun 2026
- General and administrative expense (US GAAP)32 · Mar 2020 to Jun 2026
- Increase decrease in accounts payable and accrued liabilities32 · Mar 2020 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets32 · Mar 2020 to Jun 2026
- Investment income interest32 · Mar 2020 to Jun 2026
- Lease cost32 · Mar 2020 to Jun 2026
- Net cash provided by used in financing activities32 · Mar 2020 to Jun 2026
- Net cash provided by used in investing activities32 · Mar 2020 to Jun 2026
- Net cash provided by used in operating activities32 · Mar 2020 to Jun 2026
- Net income loss32 · Mar 2020 to Jun 2026
- Nonoperating income expense32 · Mar 2020 to Jun 2026
- Operating expenses (US GAAP)32 · Mar 2020 to Jun 2026
- Operating income loss32 · Mar 2020 to Jun 2026
- Payments to acquire property plant and equipment32 · Mar 2020 to Jun 2026
- Profit loss32 · Mar 2020 to Jun 2026
- Research and development expense32 · Mar 2020 to Jun 2026
- Share based compensation32 · Mar 2020 to Jun 2026
- Stockholders equity (US GAAP)32 · Mar 2020 to Jun 2026
- Variable lease cost32 · Mar 2020 to Jun 2026
- Cash and cash equivalents at carrying value31 · Jun 2020 to Jun 2026
Product1 concepts · 8 facts · Jun 2025 to Jun 2026
- Telitacicept - gMG8 · Jun 2025 to Jun 2026
Segments
8 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or service5 members · 8 facts
- Other Research And Development2 · Jun 2025 to Jun 2026
- Trem- Cel2 · Jun 2025 to Jun 2026
- VCAR332 · Jun 2025 to Jun 2026
- Telitacicept-GMG1 · Jun 2026
- Telitacicept Sj D1 · Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.